Skip to main content

Published locations for FDA expands indication for bosutinib in newly diagnosed CML

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA expands indication for bosutinib in newly diagnosed CML

User login

  • Reset your password
  • /content/fda-expands-indication-bosutinib-newly-diagnosed-cml
  • /hematologynews/article/155352/cml/fda-expands-indication-bosutinib-newly-diagnosed-cml
  • /oncologypractice/article/155352/cml/fda-expands-indication-bosutinib-newly-diagnosed-cml
  • /hematology-oncology/article/155352/cml/fda-expands-indication-bosutinib-newly-diagnosed-cml